Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Sustainability in Pharmaceutical Pricing
How Can Pharmaceutical Public-Private Partnerships Help to Achieve the Dissemination of affordable medicines - The Case of Anti Malaria Drugs in Nigeria?
Sustainability Perspective
Many individuals from developing countries who could benefit from pharmaceuticals products do not receive them due to high costs. Antiretroviral therapy's failure in reaching more than scant numbers of individuals in developing nations, suffering from AIDS, has drawn extensive publicity. However, even far cheaper medications that can be delivered easily aren't reaching numerous individuals who require them. Over a fourth of children all over the world and more than half of the children in a few nations do not receive vaccines, which come under the World Health Organization's (WHO's) Expanded Program on Immunization. Even though these vaccines only cost a family under a dollar a dose, they still cannot afford the medicine. The lack of access to beneficial pharmaceutical products and the inability of these families to afford the required medicine results deaths of three million deaths annually (World Bank, 2001).
My company, Cure Pharmaceutical, has experienced this with the launch of their cost effective Oral Rehydration Therapy (OTF) technology in Ghana. Cure Pharmaceutical entered a licensed distribution agreement with a private...
Nonetheless, the distribution of the technology was stymied by the lack of relations with the Ghanaian government and limited financial resources dedicated to this specific disease by the distributor. In this regard, the agreement between Cure Pharmaceutical and Dan Adams Corp failed to help achieve social sustainability, which is crucial towards promoting the health and well-being of a community. According to the Western Australia Council of Social Services (WACOSS), "social sustainability occurs when the formal and informal processes, systems, structures, and relationships actively support the capacity of current and future generations to create healthy and livable communities" (AUSPA, 2012).
The pharmaceutical market in the world's poorest nations is tiny, which is a contributor to limited access to medicine. For example, more money is spent in Connecticut on healthcare compared to thirty-eight low-income sub-Saharan African nations combined (World Bank, 2001b; U.S. Census, 2000). In 1998, the United States' private and public health spending accounted for 13% of its per capita income of nearly $32,000 for an overall of above $4,000 per individual. On the other hand, low-income nations from Africa's sub-Saharan region spent only 6% of their per capita Gross Domestic Product (GDP) averaging $300 or approximately $18 per…
References
AUSPA 2012, Policy & Advocacy, Western Australian Council of Social Service Inc., viewed 10 June 2017, <http://www.wacoss.org.au/policy_and_advocacy>
Buckley, J & Seamus, T 2005, International Pricing and Distribution of Therapeutic Pharmaceuticals: An Ethical Minefield. Business Ethics, pp.127-141.
Hussein, A 2015, The Use of Triangulation in Social Sciences Research: Can Qualitative and Quantitative Methods Be Combined? Journal of Comparative Social Work, vol. 4., no.1.
Lampard, R & Pole, C 2015. Practical social investigation: qualitative and quantitative methods in social research. Routledge: Abingdon, UK.
Corporate Social Responsibility in Indian Pharmaceutical Industry An Exploratory Study Outlook of CSR in India History of CSR in India Philanthropy in Indian Society Modern Form of CSR in Indian Society Profile of Indian Pharmaceutical Industry Rationale for Selection CSR Activities by Indian Pharmaceutical Companies Major Influences Over CSR Activities Scope of CSR Activities Comparison of Indian & Western Pharmaceutical Companies This research paper is concerned with the recent practices of Indian pharmaceutical companies in the field of corporate social responsibility. For
Sustainability in Pharmaceuticals Industry Ethical Pricing in the Pharmaceutical Industry The reality of medicine if the modern era is that resources must be allocated to help support the development of new pharmaceutical and in turn, there must also be a way to compensate those who devote their resources to help cure some of the preventable diseases that plague the modern age. The moral issue at stake here is distributive justice, and Rawls'
This level of the maturity model is a transitory one and is focused more on either small, incremental gains from the first level, which is Reacting. In the Reacting layer of this proposed Branding Maturity Model, the majority of brand departments have a decidedly "every department for itself" approach to process maturity and have information flow that is purely dependent on personal productivity applications only. That is to say
Sustainable Distribution for Essential Medicines in Emerging Markets Business Case Background The Sustainable challenge Current distribution climate of Cure Pharmaceutical The growing importance of the emerging markets Barriers to growth Procurement and Distribution Challenge to overall sustainability in pharmaceutical companies Partnerships utilized in emerging markets and essential medicine distribution Suggestions of partnerships effective in essential medicine distribution Data gathering in essential medicine distribution Sustainable distribution for essential medicines in emerging markets Business Case Background This report addresses the role pharmaceuticals play in emerging
Zongshen R+d Innovations in strategic planning Organizational analysis of Chinese industrial firm, Zhongqing Zongshen Automobile Industry Manufacturing Co., Ltd., offers much in terms of understanding the global powerhouse as an industrial economy of scale. If China's macro-economic position is one of increased export growth, then micro-analyses enable us to uncover the ingenuity and strategies behind the giant. Zongshen Motorcycle brand is one of the core subsidiaries of Zongshen Industrial Group, with consumer
NAFTA Historical Beginning of NAFTA (with specific bibliography) NAFTA Objectives What is NAFTA The Promise of NAFTA NAFTA Provisions Structure of NAFTA Years of NAFTA (NAFTA not enough, other plus and minuses).. Environmental Issues Comparative Statements (Debate) NAFTA - Broken Promises NAFTA - Fact Sheet Based Assessment NAFTA & Food Regulation NAFTA - The Road Ahead NAFTA in Numbers Goal Fulfillment Major Milestones Consolidated Bibliography This study set out to examine the inner workings of the North American Free Trade Agreement. The aim of this study is